Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus - Wikidata - wikimedia - TriplyDB

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

http://www.wikidata.org/entity/Q34429198

about

Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma.The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.Esophageal COX-2 expression is increased in Barrett's esophagus, obesity, and smoking.Immunohistochemical features and staging of early gastric cancer.Aspirin Use is Associated With Lower Risk of Barrett’s Esophagus in Women.

P2860

Q26864783-CF501F9C-A0D0-49BB-932B-E654D5B78050 Q37554702-3C484300-5B76-42B1-9513-E9857754AC73 Q38368081-BB897E4F-6501-4666-B81D-B396449604C4 Q38402463-2343677E-547B-49C4-8331-E16C840AD8C1 Q46044763-AFB066D5-7E3C-4693-BDC8-C67ACC88E8CA Q47102067-85F44999-BD7E-46AC-8323-962BD4CAF03D Q49227522-914B47D7-8966-44B6-89A8-0A01858BD73A

P2860

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

http://www.wikidata.org/entity/Q34429198

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@ast

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@en

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@nl

type

label

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@ast

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@en

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@nl

prefLabel

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@ast

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@en

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@nl

P1433

Q34429198-B2DE8261-A9A3-4804-99E2-EC1E7C8BFAA2

P1476

Q34429198-495B977F-3693-49D0-8D0B-A936062F73B6

P2093

Q34429198-0A30EAA2-D82E-4ED2-B4AE-D6D508204BDE

Q34429198-2B67A511-6A05-4823-918F-19B29BAFF570

Q34429198-3B0F9266-6D59-4A3F-8F79-A3F85C4E65A2

Q34429198-99FD89EC-C852-4125-8715-8D72A7BC6D02

P2860

Q34429198-08C5547D-5310-442D-9698-F65866112272

Q34429198-191A6D9F-814F-4036-ADAD-791A97A93EB2

Q34429198-23134AA3-8A9B-425B-B762-F20BA71794D3

Q34429198-2E3B2ED4-47CE-4BB4-AEAF-F2FC1D23CE9F

Q34429198-2F682FF4-B621-45E5-A58F-8B331ABA20BF

Q34429198-33CF732F-C005-4D94-B9FA-25178EE2CCF0

Q34429198-379339E5-2DA8-4FD4-9343-1E57AA0B43D6

Q34429198-39B7C48A-EDA9-4FE5-B184-9E51CE0BD089

Q34429198-3F23E0A5-69C1-4B42-ADFB-71F0A2760C7E

Q34429198-3F28EB55-8D25-4373-B0BE-D607352442CA

P304

Q34429198-0FBA1CDE-875B-45DA-9518-CDC29ECD7E3C

P31

Q34429198-C07F290B-4934-4345-8577-488B1303D24F

P356

Q34429198-B4F76B68-D89B-4A78-8DB9-1A0DBE2FF747

P407

Q34429198-5E130711-8347-4DA6-A1C0-AA74E45BC885

P433

Q34429198-396961D7-8CC5-4FCF-95B8-6EE697067AF3

P478

Q34429198-83E579F3-33D6-4B79-B829-9DCAAFE04194

P577

Q34429198-DDF8182E-E832-44BC-8F10-3F3BA98984D2

P698

Q34429198-E2865D92-15B5-49BC-AEB4-09D503DE7F6C

P932

Q34429198-631EA5C8-88F5-4D95-A41F-825BBB85C321

P356

J.CGH.2014.04.027

P1433

Clinical Gastroenterology and Hepatology

P1476

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

@en

P2093

David Ramsey

http://www.w3.org/2001/XMLSchema#string

Hashem B El-Serag

http://www.w3.org/2001/XMLSchema#string

Natalia Khalaf

http://www.w3.org/2001/XMLSchema#string

Theresa Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis

Inflammation and cancer: back to Virchow?

The mechanism of action of aspirin

Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence

Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)

P304

1832-9.e6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2014.04.027

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24793026

http://www.w3.org/2001/XMLSchema#string

P932

4214884

http://www.w3.org/2001/XMLSchema#string